Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris

Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris

Patients with vitiligo vulgaris are treated with Pimecrolimus twice a day during 6 months. After a baseline visit, patient returns for a control visit after 3 and 6 months of treatment. One reference lesion is clinically evaluated with pictures.

Inclusion Criteria:

• Active or stable vitiligo vulgaris
• lesions at head or neck + maximum 10% lesions at the rest of the body

Exclusion Criteria:

• Topica during last 2 weeks
• Photo(chemo)therapy during last 4 weeks
• Segmentary vitiligo